TrialNature communications2025

Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer.

Esra Güç et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.